CME/CE Test

You are advising a public health department about the anticipated incidence of mycoses. According to the 2019 U.S. surveillance data by Smith and colleagues, which of the following statements about epidemiologic features of coccidioidomycosis, histoplasmosis, and blastomycosis is correct?

The number of coccidioidomycosis cases was twice as high as the number of histoplasmosis cases

Arizona and California reported 97% of blastomycosis cases

All three diseases were more common in men: 70% for blastomycosis, a substantially higher proportion than for histoplasmosis (56%) or coccidioidomycosis (52%)

States in which coccidioidomycosis is not known to be endemic had more cases in autumn

According to the 2019 surveillance data by Smith and colleagues, which of the following statements about incidence of coccidioidomycosis, histoplasmosis, and blastomycosis among racial and ethnic groups, and overall outcomes is correct?

Coccidioidomycosis incidence was approximately four times higher for non-Hispanic Black (Black) than for non-Hispanic White (White) persons

Histoplasmosis incidence was similar across racial and ethnic categories (range: 0.9-1.3)

Blastomycosis incidence was twice as high among American Indian (AI)/Alaska Native (AN) persons than among White persons

One third of histoplasmosis and blastomycosis patients were hospitalized

According to the 2019 U.S. surveillance data by Smith and colleagues, which of the following statements about clinical and public health implications of geographic distribution, populations at risk, and seasonality of coccidioidomycosis, histoplasmosis, and blastomycosis is correct?

Histoplasmosis and blastomycosis cases were not likely underdiagnosed

Coccidioidomycosis, histoplasmosis, and blastomycosis are easily distinguished from bacterial or viral pneumonia

Information from states' routine surveillance is sufficient for good public health response to these three diseases

Physicians should consider these mycoses in patients with acute lower respiratory infections who live in or travel to endemic areas

CME/CE Test

Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis — United States, 2019